Patients with IBD at Higher Risk for Myocarditis, Study Finds

  • 📰 Medscape
  • ⏱ Reading Time:
  • 29 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 32%
  • Publisher: 55%

Health News

IBD,Myocarditis,Inflammatory Bowel Disease

Patients with inflammatory bowel disease (IBD) have a higher risk for myocarditis, especially severe myocarditis, than the general population, even 20 years after diagnosis, although absolute risks are low.

Patients with inflammatory bowel disease (IBD) have a higher risk for myocarditis, especially severe myocarditis, than the general population, even 20 years after diagnosis, although absolute risks are low. Prior studies suggest that patients with IBD have an increased risk for infections and inflammation, potentially increasing the risk for myocarditis.

Researchers assessed the long-term myocarditis risk in patients with IBD from the Swedish National Patient Register and the ESPRESSO study including 24,738 patients with IBD. The study included a population-matched cohort of 391,344 individuals from the general population as a reference and a sibling-controlled cohort of 96,149 full siblings without IBD for 53,149 patients with IBD. Patients with IBD had a 50% increased risk of developing myocarditis that persisted up to 20 years after diagnosis and were 150% more likely to suffer from severe myocarditis

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 386. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Thousands of BCBSAZ patients out of network at Dignity Health, Aetna patients also at riskThousands are now out of network at Dignity, others at risk of losing coverage
Source: abc15 - 🏆 263. / 63 Read more »

How COVID-19 Treatments Affect Patients With IBDInflammatory bowel disease therapies for patients may need to be briefly halted during treatment for COVID-19, but it does not increase flares.
Source: Medscape - 🏆 386. / 55 Read more »